Additionally, epigenetic modifications, such as promoter hypermethylation of the SCGB1A1 gene in COPD patients, contribute to reduced gene expression and compromise its anti-inflammatory function (8). The gene discussed is SCGB1A1; the disease is chronic obstructive pulmonary disease.